pyrimidin-2-one beta-ribofuranoside and Carcinoma, Non-Small Cell Lung

pyrimidin-2-one beta-ribofuranoside has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Giaccone, G; Kaye, FJ; Marquez, VE; Steeg, PS; Voeller, D; Zajac-Kaye, M	1

Other Studies

1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Carcinoma, Non-Small Cell Lung

Article	Year
Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. International journal of oncology, 2010, Volume: 37, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; CpG Islands; Cytidine; Depsipeptides; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gene Deletion; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Precision Medicine; Time Factors	2010

Article

Year

Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.

International journal of oncology, 2010, Volume: 37, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; CpG Islands; Cytidine; Depsipeptides; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gene Deletion; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Precision Medicine; Time Factors

2010